ASTROS ACQUISITION SUB II, LLC – Trademark Portfolio
Entity Type: 16
ASTROS ACQUISITION SUB II, LLC holds 20 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 18 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include ACUITY, GENEPIX, DIGIDATA, IMAGEXPRESS, and AXON INSTRUMENTS. The owner is based in SUNNYVALE, CA.
1311 ORLEANS DRIVE
SUNNYVALE, CA 94089
Showing of trademarks Trademarks
Trademark Classifications
ASTROS ACQUISITION SUB II, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does ASTROS ACQUISITION SUB II, LLC have?
ASTROS ACQUISITION SUB II, LLC has 20 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 abandoned, 13 cancelled.
What trademark classes does ASTROS ACQUISITION SUB II, LLC file in?
ASTROS ACQUISITION SUB II, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are ASTROS ACQUISITION SUB II, LLC's most well-known trademarks?
ASTROS ACQUISITION SUB II, LLC's registered trademark portfolio includes well-known marks such as ACUITY, GENEPIX, DIGIDATA, IMAGEXPRESS, and AXON INSTRUMENTS. These are among 6 currently registered trademarks in the portfolio.
What is ASTROS ACQUISITION SUB II, LLC's trademark registration success rate?
ASTROS ACQUISITION SUB II, LLC has a 30% trademark registration rate, with 6 out of 20 resolved applications resulting in successful registration. Currently, 0 applications are pending review.